Correction to: The Long-Term Efficacy of a Galactagogue Containing Silymarin-Phosphatidylserine and Galega on Milk Production of Mothers of Preterm Infants by Serrao F,Corsello M,Romagnoli C,D'Andrea V,Zecca E. Breastfeed Med 2018;13(1):67–69. DOI: 10.1089/bfm.2017.0169

In the January/February 2018 issue of Breastfeeding Medicine (vol. 13, no.1, 67–69), the article titled The Long-Term Efficacy of a Galactagogue Containing Silymarin-Phosphatidylserine and Galega on Milk Production of Mothers of Preterm Infants by Serrao F et al. requires a correction because the word Silymarin was misspelled in the article title and text.

The title was published as:

“The Long-Term Efficacy of a Galactagogue Containing Sylimarin-Phosphatidylserine and Galega on Milk Production of Mothers of Preterm Infants”

The title should have appeared as:

The Long-Term Efficacy of a Galactagogue Containing Silymarin-Phosphatidylserine and Galega on Milk Production of Mothers of Preterm Infants

Silymarin was also misspelled in the first line of the Abstract:

“Aims: To investigate the efficacy of a galactagogue, containing Sylimarin-phosphatidylserine (SILITIDIL) and galega consumed in the first month after delivery by mothers of preterm infants, in maintaining milk production during the first 3–6 months after delivery.”

The sentence should have appeared as:

Aims: To investigate the efficacy of a galactagogue, containing silymarin-phosphatidylserine (SILITIDIL) and galega consumed in the first month after delivery by mothers of preterm infants, in maintaining milk production during the first 3–6 months after delivery.

The online version of the article has been corrected to reflect this change.

The publisher apologizes for the error.